Suppr超能文献

人绒毛膜促性腺激素与大鼠睾丸膜成分的相互作用。

Interaction of human chorionic gonadotropin with membrane components of rat testes.

作者信息

Pacuszka T, Osborne J C, Brady R O, Fishman P H

出版信息

Proc Natl Acad Sci U S A. 1978 Feb;75(2):764-8. doi: 10.1073/pnas.75.2.764.

Abstract

Previous studies demonstrating that gangliosides interacted with thyrotropin and human chorionic gonadotropin (hCG) suggested that gangliosides participate in the transduction of the hormonal message across the target cell membrane. As a continuation of these investigations, we examined the effects of down-regulation of hCG receptors on the interaction of hCG with rat testis membrane components. Rat testes contained a complex ganglioside pattern that did not appear to change qualitatively or quantitatively after the injection of hCG into the animals, although testis membranes from hCG-treated rats lost their capacity to bind (125)I-labeled hCG ((125)I-hCG). Gangliosides extracted from the testes of control and treated animals were equally effective inhibitors of (125)I-hCG binding to testis membranes. However, inhibition of binding was observed only under conditions (pH 6.0, low ionic strength) such that unlabeled hCG (>2500-fold excess) did not block (125)I-hCG binding, and (125)I-hCG bound similarly to testis membranes from control and treated rats. Under conditions such that hCG binding was specific (blocked by 250-fold excess of unlabeled hCG), testis gangliosides were noninhibitory. Liposomes containing gangliosides from the testes of control or hCG-treated rats bound similar small amounts of (125)I-hCG. These same liposomes bound 50 and 1000 times more thyrotropin and cholera toxin, respectively, than hCG. Oligosaccharides derived from gangliosides did not inhibit (125)I-hCG binding to testis membranes nor did they alter the fluorescence of hCG conjugated with fluorescent probes, whereas the gangliosides themselves were inhibitory and enhanced the fluorescence intensity of the hCG derivatives. Exposure of testis membranes from hCG-treated rats to 4 M MgCl(2), which displaces bound hCG [Chen, Y.-D. I. & Payne, A. H. (1977) Biochem. Biophys. Res. Commun. 74, 1589-1596], did not restore their ability to bind (125)I-hCG. When membranes were solubilized with Triton X-100, a solubilized receptor was detected from testis membranes of control but not hCG-treated rats. These findings and the absence of demonstrable changes in the composition or quantity of rat testis gangliosides when hCG receptors are down-regulated suggest that gangliosides do not represent the primary binding determinants of hCG receptors.

摘要

先前的研究表明神经节苷脂与促甲状腺激素及人绒毛膜促性腺激素(hCG)相互作用,这提示神经节苷脂参与激素信息跨靶细胞膜的转导。作为这些研究的延续,我们检测了hCG受体下调对hCG与大鼠睾丸膜成分相互作用的影响。大鼠睾丸含有复杂的神经节苷脂模式,在给动物注射hCG后,其在质量或数量上似乎没有变化,尽管来自hCG处理大鼠的睾丸膜失去了结合(125)I标记的hCG((125)I-hCG)的能力。从对照动物和处理动物的睾丸中提取的神经节苷脂对(125)I-hCG与睾丸膜的结合具有同等有效的抑制作用。然而,仅在未标记的hCG(超过2500倍过量)不阻断(125)I-hCG结合的条件下(pH 6.0,低离子强度)观察到结合抑制,并且(125)I-hCG与对照大鼠和处理大鼠的睾丸膜的结合相似。在hCG结合具有特异性(被250倍过量的未标记hCG阻断)的条件下,睾丸神经节苷脂无抑制作用。含有来自对照或hCG处理大鼠睾丸神经节苷脂的脂质体结合的(125)I-hCG量相似。这些相同的脂质体结合的促甲状腺激素和霍乱毒素分别比hCG多50倍和1000倍。源自神经节苷脂的寡糖既不抑制(125)I-hCG与睾丸膜的结合,也不改变与荧光探针偶联的hCG的荧光,而神经节苷脂本身具有抑制作用并增强了hCG衍生物的荧光强度。将来自hCG处理大鼠的睾丸膜暴露于4M MgCl2(其可置换结合的hCG [Chen, Y.-D. I. & Payne, A. H. (1977) Biochem. Biophys. Res. Commun. 74, 1589 - 1596])并不能恢复其结合(125)I-hCG的能力。当用Triton X-100溶解膜时,从对照大鼠而非hCG处理大鼠的睾丸膜中检测到一种可溶解的受体。这些发现以及当hCG受体下调时大鼠睾丸神经节苷脂的组成或数量没有明显变化表明神经节苷脂不代表hCG受体的主要结合决定因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/411337/36ee03eb331a/pnas00014-0237-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验